Halogen bonding in halocarbon-protein complexes: a structural survey.

Halogen bonding has been extensively described in the context of a variety of self-assembled supramolecular systems and efficiently utilized in the rational design of materials with specific structural properties. However, it has so far received only little recognition for its possible role in the stabilization of small molecule-protein complexes. In this tutorial review, we provide a few examples of halogen bonds occurring between small halogen-substituted ligands and their biological substrates. Examples were drawn from a diverse set of compounds, ranging from chemical additives and possible environmental agents such as triclosan to pharmacologically active principles such as the volatile anesthetic halothane or HIV-1 reverse transcriptase inhibitors or a subset of non-steroidal anti-inflammatory drugs (NSAIDs) that are halogen-substituted. The crystal structures presented here, where iodine, bromine, or chlorine atoms function as halogen bonding donors and a variety of electron rich sites, such as oxygen, nitrogen and sulfur atoms, as well as aromatic π-electron systems, function as halogen bonding acceptors, prove how halogen bonds can occur in biological systems and provide a class of highly directional stabilizing contacts that can be exploited in the process of rational drug design.

[1]  O. El-Kabbani,et al.  Studies on the inhibitor‐binding site of porcine aldehyde reductase: Crystal structure of the holoenzyme‐inhibitor ternary complex , 1997, Proteins.

[2]  Brian W Matthews,et al.  Halogenated benzenes bound within a non-polar cavity in T4 lysozyme provide examples of I...S and I...Se halogen-bonding. , 2009, Journal of molecular biology.

[3]  A. Whitwood,et al.  Mesogenic, trimeric, halogen-bonded complexes from alkoxystilbazoles and 1,4-diiodotetrafluorobenzene , 2008 .

[4]  A. Bondi.  van der Waals Volumes and Radii , 1964 .

[5]  K. Hwang,et al.  Structural insights into Staphylococcus aureus enoyl‐ACP reductase (FabI), in complex with NADP and triclosan , 2010, Proteins.

[6]  Joel S. Freundlich,et al.  The fatty acid biosynthesis enzyme FabI plays a key role in the development of liver-stage malarial parasites. , 2008, Cell host & microbe.

[7]  Pierangelo Metrangolo,et al.  Fluorinated liquid crystals formed by halogen bonding. , 2006, Chemical communications.

[8]  O. El-Kabbani,et al.  Structure of human aldose reductase holoenzyme in complex with Statil: An approach to structure‐based inhibitor design of the enzyme , 2002, Proteins.

[9]  Lawrence J Marnett,et al.  A Novel Mechanism of Cyclooxygenase-2 Inhibition Involving Interactions with Ser-530 and Tyr-385* , 2003, Journal of Biological Chemistry.

[10]  P. Hajduk,et al.  Discovering High-Affinity Ligands for Proteins: SAR by NMR , 1996, Science.

[11]  Debbie C. Mulhearn,et al.  Design and Synthesis of Aryl Ether Inhibitors of the Bacillus Anthracis Enoyl‐ACP Reductase , 2008, ChemMedChem.

[12]  Pierangelo Metrangolo,et al.  Halogen bonding based recognition processes: a world parallel to hydrogen bonding. , 2005, Accounts of chemical research.

[13]  Stefan Güssregen,et al.  Evidence for C-Cl/C-Br...pi interactions as an important contribution to protein-ligand binding affinity. , 2009, Angewandte Chemie.

[14]  Weiliang Zhu,et al.  Halogen bonding--a novel interaction for rational drug design? , 2009, Journal of medicinal chemistry.

[15]  Yong-Jun Jiang,et al.  Ab initio study of the complexes of halogen-containing molecules RX (X=Cl, Br, and I) and NH3: towards understanding the nature of halogen bonding and the electron-accepting propensities of covalently bonded halogen atoms. , 2005, Chemistry.

[16]  Eric Westhof,et al.  Halogen bonds in biological molecules. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[17]  Christophe Meyer,et al.  Crystal structures for HIV-1 reverse transcriptase in complexes with three pyridinone derivatives: a new class of non-nucleoside inhibitors effective against a broad range of drug-resistant strains. , 2005, Journal of medicinal chemistry.

[18]  P. Metrangolo,et al.  Halogen bonding: a paradigm in supramolecular chemistry. , 2001, Chemistry.

[19]  P Shing Ho,et al.  Halogen bonds as orthogonal molecular interactions to hydrogen bonds. , 2009, Nature chemistry.

[20]  The structure of human aldose reductase bound to the inhibitor IDD384. , 2000, Acta crystallographica. Section D, Biological crystallography.

[21]  P. Metrangolo,et al.  Halogen Versus Hydrogen , 2008, Science.

[22]  P. S. Ho,et al.  Effect of sequence on the conformation of DNA holliday junctions. , 2003, Biochemistry.

[23]  Joel S. Freundlich,et al.  Triclosan Derivatives: Towards Potent Inhibitors of Drug‐Sensitive and Drug‐Resistant Mycobacterium tuberculosis , 2009, ChemMedChem.

[24]  C. A. Bayse,et al.  Is halogen bonding the basis for iodothyronine deiodinase activity? , 2010, Inorganic chemistry.

[25]  P Voth Regier Andrea and Ho Shing,et al.  The role of halogen bonding in inhibitor recognition and binding by protein kinases. , 2007 .

[26]  Frank H. Allen,et al.  The Nature and Geometry of Intermolecular Interactions between Halogens and Oxygen or Nitrogen , 1996 .

[27]  C David Stout,et al.  Structure of mammalian cytochrome P450 2C5 complexed with diclofenac at 2.1 A resolution: evidence for an induced fit model of substrate binding. , 2003, Biochemistry.

[28]  P. Metrangolo,et al.  Metric engineering of perfluorocarbon-hydrocarbon layered solids driven by the halogen bonding. , 2004, Chemical communications.

[29]  Pierangelo Metrangolo,et al.  Halogen bonding in supramolecular chemistry. , 2008, Angewandte Chemie.

[30]  Feifei Tian,et al.  Halogen-water-hydrogen bridges in biomolecules. , 2010, Journal of structural biology.

[31]  Yong-Jun Jiang,et al.  Ab initio investigation of the complexes between bromobenzene and several electron donors: some insights into the magnitude and nature of halogen bonding interactions. , 2007, The journal of physical chemistry. A.

[32]  P Shing Ho,et al.  Directing macromolecular conformation through halogen bonds , 2007, Proceedings of the National Academy of Sciences.

[33]  S. Curry,et al.  Structural basis of the drug-binding specificity of human serum albumin. , 2005, Journal of molecular biology.

[34]  R. Heath,et al.  The Enoyl-[acyl-carrier-protein] Reductases FabI and FabL fromBacillus subtilis * , 2000, The Journal of Biological Chemistry.

[35]  P. Metrangolo,et al.  Supramolecular Route to Fluorinated Coatings: Self-Assembly Between Poly(4-vinylpyridines) and Haloperfluorocarbons , 2002 .

[36]  Peter Politzer,et al.  Expansion of the σ-hole concept , 2009, Journal of molecular modeling.

[37]  R. Eckenhoff,et al.  Structural basis for high‐affinity volatile anesthetic binding in a natural 4‐helix bundle protein , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[38]  William J. Welsh,et al.  Halogenated ligands and their interactions with amino acids: implications for structure-activity and structure-toxicity relationships. , 2008, Journal of molecular graphics & modelling.

[39]  R E Cachau,et al.  Ultrahigh resolution drug design I: Details of interactions in human aldose reductase–inhibitor complex at 0.66 Å , 2004, Proteins.

[40]  Punit Kaur,et al.  The structural basis for the prevention of nonsteroidal antiinflammatory drug-induced gastrointestinal tract damage by the C-lobe of bovine colostrum lactoferrin. , 2009, Biophysical journal.

[41]  Lawrence J. Marnett,et al.  Structural Basis of Enantioselective Inhibition of Cyclooxygenase-1 by S-α-Substituted Indomethacin Ethanolamides* , 2007, Journal of Biological Chemistry.

[42]  Weiliang Zhu,et al.  Nonbonding interactions of organic halogens in biological systems: implications for drug discovery and biomolecular design. , 2010, Physical chemistry chemical physics : PCCP.

[43]  Peter Politzer,et al.  An overview of halogen bonding , 2007, Journal of molecular modeling.

[44]  G. Mugesh,et al.  Interaction of heterocyclic thiols/thiones eliminated from cephalosporins with iodine and its biological implications. , 2010, Bioorganic & medicinal chemistry letters.

[45]  A. Whitwood,et al.  Structure-function relationships in liquid-crystalline halogen-bonded complexes. , 2010, Chemistry.

[46]  P. Metrangolo,et al.  Crystal Engineering through Halogen Bonding: Complexes of Nitrogen Heterocycles with Organic Iodides , 2001 .